# US 2015/0088238 A1 · Method for coating devices using electrospinning

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0088238 A1
- Document ID: US20150088238A1
- Status: Published application
- Kind: A1
- Application number: 14/556,818
- Filed: 2014-12-01
- Published: 2015-03-26
- Earliest claimed: 2011-08-12
- Assignees: Cardiac Pacemakers, Inc.
- Applicants: Cardiac Pacemakers, Inc.
- Inventors: Devon N. Arnholt; Douglas D. Pagoria; Jeannette C. Polkinghorne; Joseph T. Delaney, JR.
- Web page: https://patentgrep.com/patent/US20150088238A1

## CPC

- A61N 1/05: for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence)
- A61N 1/056: {Transvascular endocardial electrode systems}
- D01D 5/0023: {the material being a polymer melt}
- D01D 5/0084: {Coating by electro-spinning, i.e. the electro-spun fibres are not removed from the collecting device but remain integral with it, e.g. coating of prostheses}
- D10B 2321/08: polymers of unsaturated carboxylic acids or unsaturated organic esters, e.g. polyacrylic esters, polyvinyl acetate
- D10B 2331/06: polyethers
- Y10T 29/4922: with molding of insulation
- Y10T 29/49224: with coating
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- D01D: MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D10B: INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

A medical electrical lead may include an insulative lead body, a conductor disposed within the insulative lead body, an electrode disposed on the insulative lead body and in electrical contact with the conductor and a fibrous matrix disposed at least partially over the electrode. The fibrous matrix may be formed from polytetrafluoroethylene.

## Claims

### Claim 1

A medical electrical lead comprising:
an insulative lead body extending from a distal region to a proximal region;
a conductor disposed within the insulative lead body and extending from the proximal region to the distal region;
an electrode disposed on the insulative lead body and in electrical contact with the conductor; and
a non-conductive fibrous matrix comprising polytetrafluoroethylene disposed at least partially over the electrode, the fibrous matrix having an average fiber diameter between 40 nanometers and 800 nanometers, and an average thickness between about 2.54 microns and about 254 microns.

### Claim 2 (depends on 1)

The medical electrical lead of claim 1, wherein the fibrous matrix comprises electrospun polytetrafluoroethylene.

### Claim 3 (depends on 1)

The medical electrical lead of claim 1, wherein the fibrous matrix has sufficient fiber-to-fiber spacing to deliver electrophysiological therapy through the matrix.

### Claim 4 (depends on 3)

The medical electrical lead of claim 3, wherein the fibrous matrix has an average fiber-to-fiber spacing between about 10 microns to about 50 microns.

### Claim 5 (depends on 4)

The medical electrical lead of claim 4, wherein the fibrous matrix has an average fiber-to-fiber spacing between about 10 microns to about 25 microns.

### Claim 6 (depends on 1)

The medical electrical lead of claim 1, further including a material on a surface of the fibrous matrix, wherein the material increases wettability of the surface as compared to the surface without the material.

### Claim 7 (depends on 6)

The medical electrical lead of claim 6, wherein the material is poly(ethylene glycol) dimethacrylate.

### Claim 8

A method of forming a medical electrical lead having an insulative lead body and an electrode disposed on the insulative lead body, the method comprising steps of:
forming a fibrous matrix comprising polytetrafluoroethylene polymer by electrospinning; and
disposing the fibrous matrix at least partially over the electrode;
wherein the fibrous matrix has an average fiber diameter between 40 nanometers and 800 nanometers and an average thickness between about 2.54 microns and 254 microns.

### Claim 9 (depends on 8)

The method of claim 8, wherein forming the fibrous matrix comprises forming the fibrous matrix directly onto the electrode.

### Claim 10 (depends on 8)

The method of claim 8, wherein forming the fibrous matrix comprises forming the fibrous matrix on a substrate and then depositing the fibrous matrix at least partially over the electrode.

### Claim 11 (depends on 8)

The method of claim 8, further including treating a surface of the fibrous matrix with a material that increases wettability of the surface as compared to the surface prior to the treating.

### Claim 12 (depends on 11)

The method of claim 11, wherein the material is poly(ethylene glycol) dimethacrylate.

### Claim 13 (depends on 8)

The method of claim 8, wherein the fibrous matrix has sufficient fiber-to-fiber spacing to deliver electrophysiological therapy through the matrix.

### Claim 14 (depends on 13)

The method of claim 13, wherein the fibrous matrix has an average fiber-to-fiber spacing between about 10 microns to about 50 microns.

### Claim 15 (depends on 14)

The method of claim 14, wherein the fibrous matrix has an average fiber-to-fiber spacing between about 10 microns to about 25 microns.

### Claim 16

A medical electrical lead comprising:
an insulative lead body extending from a distal region to a proximal region;
a conductor disposed within the insulative lead body and extending from the proximal region to the distal region;
an electrode disposed on the insulative lead body and in electrical contact with the conductor; and
a fibrous matrix comprising electrospun polytetrafluoroethylene disposed at least partially over the electrode, the fibrous matrix having an average fiber diameter between 40 nanometers and 800 nanometers.

### Claim 17 (depends on 16)

The medical electrical lead of claim 16, further including a material on a surface of the fibrous matrix, wherein the material increases wettability of the surface as compared to the surface without the material.

### Claim 18 (depends on 16)

The medical electrical lead of claim 16, wherein the fibrous matrix has an average fiber-to-fiber spacing between about 10 microns to about 50 microns.

### Claim 19 (depends on 16)

The medical electrical lead of claim 16, wherein the fibrous matrix further includes dopant material to facilitate polymer conductivity.

### Claim 20 (depends on 19)

The medical electrical lead of claim 19, wherein the dopant material is less than 5 weight percent of the fibrous matrix.
